BWhat changed
Used graph-based explanations to prioritize a structural class with antibacterial activity, followed by laboratory and mouse-infection experiments.
Scientific scope
Used graph-based explanations to prioritize a structural class with antibacterial activity, followed by laboratory and mouse-infection experiments. Scope limitation: The article appeared online in December 2023 and in the February 2024 issue. Preclinical evidence is not clinical approval or proof of effectiveness in humans.
Evidence
Assessment uses the catalogue-linked source evidence for the stated contribution. The article appeared online in December 2023 and in the February 2024 issue. Preclinical evidence is not clinical approval or proof of effectiveness in humans.
Contributors
- The research collaboration listed in the linked record and source byline · SCIENCE: Collective scoped contribution. The complete recorded byline remains in the research record; this label does not collapse people into one individual.
- The systems documented in the research record · EXECUTION: Source-reported system assistance within this scope; no provider attestation or independent agency is inferred.
- Discovery of a structural class of antibiotics with explainable deep learning
- Discovery of a structural class of antibiotics with explainable deep learning — deposited bibliography
- Open full paper
Provisional WRS assessment, edition 2026-10-16.1. Independent expert calibration is pending. This grade does not certify correctness or assign ownership.
Full scientific record · Browse contribution grades · Request a correction